Studies have shown EECP is a means of improving perfusion (blood supply) to other
organs of the body than just the heart.
Studies also support a positive clinical benefit for:
Restless leg syndrome
Mild peripheral vascular disease
Further studies suggest there may well be effective clinical applications for EECP
in other pathology such as increasing re-perfusion after:
cerebral ischaemia (stroke)
There is an increasing trend internationally for patients who have significant risk
factors such as obesity, strong family history of heart disease, high cholesterol,
diabetes, smoking and high blood pressure to undergo self-funded EECP treatment on
a prophylactic basis (i.e. before the onset of angina or heart problems).
There are also applications for sports injury recovery and rehabilitation.